BG108256A - Интерферон-гама полипептидни разновидности - Google Patents

Интерферон-гама полипептидни разновидности Download PDF

Info

Publication number
BG108256A
BG108256A BG108256A BG10825603A BG108256A BG 108256 A BG108256 A BG 108256A BG 108256 A BG108256 A BG 108256A BG 10825603 A BG10825603 A BG 10825603A BG 108256 A BG108256 A BG 108256A
Authority
BG
Bulgaria
Prior art keywords
polypeptide
interferon
gamma
seq
amino acid
Prior art date
Application number
BG108256A
Other languages
Bulgarian (bg)
English (en)
Inventor
Anne Jensen
Original Assignee
Maxygen Holdings Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Holdings Ltd. filed Critical Maxygen Holdings Ltd.
Publication of BG108256A publication Critical patent/BG108256A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
BG108256A 2001-04-06 2003-10-10 Интерферон-гама полипептидни разновидности BG108256A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200100579 2001-04-06
DKPA200100714 2001-05-07
DKPA200200198 2002-02-11

Publications (1)

Publication Number Publication Date
BG108256A true BG108256A (bg) 2004-12-30

Family

ID=27222504

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108256A BG108256A (bg) 2001-04-06 2003-10-10 Интерферон-гама полипептидни разновидности

Country Status (15)

Country Link
EP (1) EP1412382A2 (zh)
JP (1) JP2005518183A (zh)
KR (1) KR20030094336A (zh)
CN (1) CN1257186C (zh)
BG (1) BG108256A (zh)
BR (1) BR0208596A (zh)
CA (1) CA2443277A1 (zh)
HK (1) HK1069834A1 (zh)
HU (1) HUP0303645A3 (zh)
IL (1) IL157896A0 (zh)
MX (1) MXPA03009082A (zh)
NO (1) NO20034432L (zh)
NZ (1) NZ528651A (zh)
PL (1) PL366705A1 (zh)
WO (1) WO2002081507A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070172446A1 (en) 2003-05-16 2007-07-26 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
JP4707327B2 (ja) * 2004-01-27 2011-06-22 旭化成ファーマ株式会社 ポリペプタイド類の吸着防止剤
CA2576030A1 (en) * 2004-08-09 2006-02-23 Alios Biopharma Inc. Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
CN103550757A (zh) * 2005-09-20 2014-02-05 纽约大学 用干扰素治疗肺病的方法
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
JP5769142B2 (ja) * 2007-09-04 2015-08-26 独立行政法人酒類総合研究所 ピヒア属酵母において異種タンパク質を高分泌させる方法
EP2039764A1 (en) * 2007-09-19 2009-03-25 Pevion Biotech AG Truncated secretory aspartyl proteinase 2
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
RU2446821C2 (ru) * 2010-07-15 2012-04-10 Олег Ильич Эпштейн Лекарственное средство для лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способ лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями
GB201621728D0 (en) 2016-12-20 2017-02-01 Ucb Biopharma Sprl Methods
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон
WO2023182947A1 (en) * 2022-03-22 2023-09-28 Chiang Mai University A modified protein of interferon gamma and its use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
BG52073B2 (en) * 1990-01-24 1996-04-30 Inst Molekuljarna Biolog Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine
DE4036856C1 (zh) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De

Also Published As

Publication number Publication date
NO20034432L (no) 2003-10-29
JP2005518183A (ja) 2005-06-23
CN1537117A (zh) 2004-10-13
HUP0303645A2 (hu) 2004-01-28
KR20030094336A (ko) 2003-12-11
NZ528651A (en) 2006-06-30
PL366705A1 (en) 2005-02-07
HK1069834A1 (en) 2005-06-03
EP1412382A2 (en) 2004-04-28
WO2002081507A2 (en) 2002-10-17
IL157896A0 (en) 2004-03-28
BR0208596A (pt) 2004-03-09
WO2002081507A3 (en) 2004-02-12
HUP0303645A3 (en) 2005-12-28
CN1257186C (zh) 2006-05-24
CA2443277A1 (en) 2002-10-17
NO20034432D0 (no) 2003-10-03
MXPA03009082A (es) 2004-11-22

Similar Documents

Publication Publication Date Title
US7232562B2 (en) E38N interferon gamma polypeptide variants
US7419805B2 (en) Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression
EP1366075A2 (en) New interferon beta-like molecules
US7390638B2 (en) S99T C-11 Truncated polynucleotides encoding interferon gamma polypeptide variants
EP1257574A1 (en) Improved interleukin 10
BG108256A (bg) Интерферон-гама полипептидни разновидности
US7230081B1 (en) Interferon gamma conjugates
US7524931B2 (en) Full-length interferon gamma polypeptide variants
RU2268749C2 (ru) КОНЪЮГАТЫ γ-ИНТЕРФЕРОНА
RU2296130C2 (ru) Варианты полипептида гамма-интерферона
AU2002252971B2 (en) Interferon gamma polypeptide variants
AU782635B2 (en) Interferon gamma conjugates
AU2002252971A1 (en) Interferon gamma polypeptide variants
ZA200308376B (en) Interferon gamma polypeptide variants.
CZ20033016A3 (cs) Varianty polpeptidu interferonu gamma
CN101172160A (zh) 干扰素γ偶联物